Literature DB >> 560339

[Pharmacological studies of Shikon and Tooki. (2) Pharmacological effects of the pigment components, Shikonin and acetylshikonin].

M Hayashi.   

Abstract

Pharmacological effects of Shikonin and Acetylshikonin, pigment components of Shikon were studied in mice, rats, guinea pigs and rabbits. The only difference between the chemical structures of the two pigments is that Acetylshikonin has the acetyl radical, while Shikonin does not. Though the activity was slightly different between the two compounds, the pharmacological effect of Shikonin was similar to that of Acetylshikonin. As the two pigments were extracted by ether from Shikon, systemic administration of these pigments showed the same effect as that of ether extract of Shikon as outlined in the first report(1). These compounds had no effect on blood coagulation, but inhibited the anticoagulant effect of heparin in rats. Topical application of both pigments (50 mg of 0.1% ointment) inhibited an increased vascular permeability and acute edema induced by histamine, anti-rat rabbit serum and heat. The activity was similar to that of 0.1% phenylbutazone ointment. On the other hand, these pigments increased proliferation of granuloma tissue in the cotton pellet method and promoted would healing in rats. The results suggest that Shiunko, a main prescription of Shikon, is an effective ointment for cutaneous injuries.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 560339

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  6 in total

1.  Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.

Authors:  Jianqing Peng; Wen Zhou; Xinyi Xia; Xiaole Qi; Luan Sun; Min Wang; Zhenghong Wu; Zhengrong Li
Journal:  AAPS PharmSciTech       Date:  2014-01-22       Impact factor: 3.246

2.  Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma.

Authors:  Chen-Chen Lee; Chien-Neng Wang; Yu-Ting Lai; Jaw-Jou Kang; Jiunn-Wang Liao; Bor-Luen Chiang; Hui-Chen Chen; Yu-Wen Cheng
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Evaluation of the effectiveness of an ointment based on Alkannins/Shikonins on second intention wound healing in the dog.

Authors:  Maria Karayannopoulou; Vassiliki Tsioli; Panayiotis Loukopoulos; Tilemahos L Anagnostou; Nikolaos Giannakas; Ioannis Savvas; Lysimachos G Papazoglou; Eleni Kaldrymidou
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

4.  Anticancer agent shikonin is an incompetent inducer of cancer drug resistance.

Authors:  Hao Wu; Jiansheng Xie; Qiangrong Pan; Beibei Wang; Danqing Hu; Xun Hu
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

5.  Shikonin suppresses ERK 1/2 phosphorylation during the early stages of adipocyte differentiation in 3T3-L1 cells.

Authors:  So Young Gwon; Ji Yun Ahn; Chang Hwa Jung; Bo Kyung Moon; Tae Youl Ha
Journal:  BMC Complement Altern Med       Date:  2013-08-06       Impact factor: 3.659

Review 6.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.